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Can food be addictive? What does it mean to be a food addict? Do common underlying 
neurobiological mechanisms contribute to drug and food addiction? These vexing questions 
have been the subject of considerable interest and debate in recent years, driven in large part 
by the major health concerns associated with dramatically increasing body weights and rates of 
obesity in the United States, Europe and other regions with developed economies. No clear 
consensus has yet emerged on the validity of the concept of food addiction and whether some 
individuals who struggle to control their food intake can be considered food addicts. Some, 
including Fletcher, have argued that the concept of food addiction is unsupported, as many of 
the defining features of drug addiction are not seen in the context of feeding behaviors. Others, 
Kenny included, have argued that food and drug addiction share similar features that may 
reflect common underlying neural mechanisms. Here, Fletcher and Kenny argue the merits of 
these opposing positions on the concept of food addiction. 
 
ARGUMENTS AGAINST FOOD ADDICTION (FLETCHER) 
 
“I am asked by the learned doctor the cause and reason why 
opium causes sleep. To which I reply: because it has a dormitive 
property [virtus dormitiva], whose nature is to lull the senses to 
sleep.” 
 
- Moliere, La malade imaginaire 
 
Applying diagnoses to make sense of collections of symptoms and behaviors has advantages in 
sharpening communication and clarifying thought. It may carry benefits for the patient, too, 
offering a model that seems to make sense of what is otherwise baffling. But the hope, if we 
are simply to avoid the circularity alluded to in the quote above or, as Jaspers put it ‘pseudo-
insight through terminology’ (Jaspers, 1963), is to go beyond simple naming and to reach an 
understanding of processes and mechanisms. The application of the term ‘food addiction’ in 
humans is based on a set of features, held to resemble substance addictions. It carries the claim 
that this resemblance occurs because certain foods have effects on the brain comparable to 
those of addictive drugs. I suggest that there are problems with both of these claims. The first is 
questionable as the central features of substance addiction do not plausibly translate to food 
and consumption. The second because the assertion that foods have pharmacological effects 
on the brain demands strong and convincing evidence which has not been found.  
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Food addiction, as an explanation for the often-distressing cravings, loss of control and over-
consumption experienced by many, particularly in relation to highly palatable foods, has been 
with us for many years (see (Davis, 2014)) and, having more latterly become a focus for direct 
scientific study, the model has sought support in two broad sets of work. First, clinico-
behavioral work has produced a descriptive framework based on the asserted resemblance 
between over-consumption of food and substance use. This has led to the development of a 
widely-used scale (Gearhardt et al, 2009), which measures the characteristics thought to be 
common to substance and, putatively, food addiction (i.e., craving, loss of control, excessive 
consumption, tolerance, withdrawal and distress/dysfunction). Scores on this scale have 
subsequently been used as the basis for interpreting variance in functional neuroimaging 
measures, with such correlations being cited as evidence for the neurobiological reality of food 
addiction. Second, insights into the neurobiology of substance use and addiction have 
generated hypotheses in rodent and human work, particularly focusing on reward processing 
and the mesolimbic dopamine system. Such studies have established that particular regimens 
of palatable food availability may produce addiction-like brain changes, as well as binge-like 
eating and withdrawal symptoms. It is important to acknowledge that there are some differing 
positions held by supporters of the food addiction model, but the prevailing view seems 
reasonably characterized as follows: with exceptions (Volkow et al, 2013) food addiction is 
considered as separable from obesity. While one study shows that 88% meeting criteria for 
food addiction are obese (Pedram et al, 2013), it is important to note that food addiction is 
defined by behavioral patterns and experiences relating to eating rather than by weight status. 
Moreover, it is considered to be separate from those established clinical conditions with which 
it markedly overlaps, notably eating disorders marked by binge eating (Davis, 2014). It is 
identified by some self-reported combination of the above features and held to resemble a 
substance addiction rather than a behavioral addiction (though see (Hebebrand et al, 2014)), 
such as Gambling Disorder (Schulte et al, 2017). Critically, the suggestion goes, it is associated 
with corresponding changes to the mesolimbic dopamine system, changes which underpin the 
transition from reward-driven to impulsive and compulsive eating. 
 
There are several problems with this model. First, the addictive substance remains 
undiscovered – a problem that must not be considered trivial. The model rests on a central 
assertion that either some category of foods, or some specific nutrients, exert a direct effect on 
the brain, enacting changes that ultimately hijack reward-related behaviors. Some have argued 
that sugar is the culprit though, as a whole, the evidence for sugar addiction remains deeply 
unconvincing (Westwater et al, 2016). Alternatively, others maintain that the refined and 
excessively palatable combinations of sugars and fats in Western diets increase addiction 
liability. But, as of yet, no addictive substance has been identified. Second, there are crucial 
questions relating to how food addiction fits into the overall schema of problematic eating. 
Though initially applied to understand obesity as a whole, the current view is that food 
addiction represents a specific construct that is strongly argued to be distinct even from the 
eating disorder that perhaps it most resembles: binge-eating disorder (Davis, 2014). This clear 
distinction is challenged, however, by studies showing marked overlap between positive scores 
for food addiction (as measured on a dedicated scale – the Yale Food Addiction Scale (see 
below) and binge eating in the context of bulimia nervosa (de Vries and Meule, 2016; Hilker et 
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al, 2016; Meule et al, 2012; Meule et al, 2014) and the overlap too between food addiction and 
binge-eating disorder is striking (Gearhardt et al, 2012). One conclusion from this might be that 
food addiction is not distinct from the symptom of binge eating, perhaps with food addiction 
(and its putative underlying neurobiological imbalance) providing a mechanistic explanation for 
the latter. However, it has been argued that these are distinct entities and should not be 
conflated (Davis, 2014). There is a pressing need, therefore to assess the discriminant validity of 
the scale.  It is crucial, too, that we consider the validity and reliability of other characteristics 
held to be a feature of food addiction, most notably tolerance and withdrawal. For example, 
eating increased amounts of food and obtaining less pleasure from eating is taken as evidence 
of tolerance while anxiety, dysphoria and unspecified “physical symptoms” during abstinence 
from certain foods are viewed as withdrawal symptoms. It is inevitable that brief, non-
interactive clinical scales will be imprecise. It is important, though, that scales are not taken to 
validate the phenomenon that they are seeking to measure (Finlayson, 2017). Further 
considerations of the problems in applying the diagnosis of food addiction clinically have been 
discussed elsewhere (Finlayson, 2017; Long et al, 2015). 
 
Going beyond the phenotype, a critical aspect of the model, and one that moves it beyond a 
simple phenomenological description of a cluster of behaviors and symptoms, is the 
hypothesized set of neurobiological changes that underlie food addiction. The third concern 
therefore is especially important:  there remains no convincing demonstration in humans that 
such neurobiological changes do indeed underlie these food addiction behaviors. We should 
see specifically altered structural and functional patterns in key nodes of the mesolimbic 
dopamine system in groups of individuals who exhibit food addiction behaviors. An early study 
suggested that this was indeed the case with reduced striatal dopamine receptor density in 
severely obese people (Wang et al, 2001). But this finding, which is frequently cited in 
unqualified support for the food addiction model of obesity, has not been replicated and has 
been succeeded by several studies which do not find such differences; e.g., (Dang et al, 2016; 
Eisenstein et al, 2015; Karlsson et al, 2015). Reviewing the literature some five years ago, I and 
colleagues (Ziauddeen et al, 2012; Ziauddeen and Fletcher, 2013) suggested that existing 
functional MRI and PET studies should not be used as a basis for making claims about food 
addiction. Reviewing the field now there is no more support for food addiction from human 
neuroimaging literature than there was then. Indeed, there is less.  
 
Fourth, there are several studies showing that controlled manipulation of food composition and 
availability provoke addiction-like patterns in rats. These studies convincingly demonstrate that 
experimentally constrained, intermittent availability of high sugar, high fat or high-sugar plus 
high fat diets provoke both compulsive patterns of eating in rats and a number of sequelae 
suggestive of addiction: notably, reduced dopamine receptor function, increased self-
stimulation thresholds and, in the case of sugar, anxious behaviors that may be relatable to 
withdrawal symptoms. Such studies constitute the most compelling evidence that highly 
palatable foods administered intermittently can produce changes in brain and behavior that 
replicate substance addiction. But, outstanding questions remain about whether and how these 
carefully-controlled regimens translate to humans who, by and large, inhabit a very different 
food environment, one that is often characterized by constant and plentiful availability rather 
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than constraint. To be clear, I do not deny the importance and value of these rodent models in 
developing our understanding of perturbations in food behaviors, but their emergence 
challenges us to translate them to humans, a challenge that has not been met. And it should be 
noted too that they raise important questions (see (Westwater et al, 2016) for fuller 
discussion): for example, it has been argued that it is the uncertainty of availability, rather than 
the emergence of addiction, that generates compulsive eating (Corwin, 2011). Moreover, while 
rats with intermittent access to a high calorie food develop habit-like responding and 
corresponding activation in dorsolateral striatum, those with continued access to the same 
foods do not show this pattern (Furlong et al, 2014). 
 
When first expressing misgivings about the ready acceptance of food addiction as an 
explanation for obesity (Ziauddeen et al, 2012), our paper generated a brief correspondence 
(Avena et al, 2012) in which we all concluded with the clichéd but invariably true suggestion 
that “more research is needed”. Reviewing the current literature, I suggest that little clarity has 
emerged: the case has not been further made that there is a convincing resemblance between 
problem food behaviors and substance addiction. Attempts to pinpoint the neurobiology of 
food addiction in humans has generated no consistent or replicated finding, overall failing to 
support the model and, in many areas, seeming quite strongly to contradict it. Furthermore, the 
most promising area of research, the modelling of addictive-like eating in rodents, has not 
progressed appreciably and, importantly, has not been followed up in humans in a systematic 
way. And yet, there is a continued willingness to diagnose, measure and apply food addiction as 
a validated concept in research. 
 
The strong narrative around food addiction is, of course, understandable. A person prone to 
binges or over-eating in general feels powerful cravings to consume; they often see little option 
but to succumb to these cravings, and this capitulation is a matter of shame and guilt. The 
language of addiction – ‘this is a biological drive that I alone cannot control’ – fits well with this 
subjective experience, and it brings a means of communicating distress and helplessness. It may 
even be helpful in resisting cravings, though whether it is or not is an empirical question that 
has not been resolved. It is not for the scientist or clinician to police popular language. When a 
person asserts that they are addicted to sugar, they acknowledge and convey a distressing 
sense of helplessness and compulsion. The science narrative that is offered that food, like a 
drug, has affected a person’s brain such that their inhibitory control centers do not work 
properly, and their reward centers are malfunctioning, is simple and readily accepted. But, the 
scientist who offers this as the explanation had better be sure that the evidence exists to 
support it. My view is that it does not. Lacking this evidence, I suggest, severely constrains the 
explanatory power of the food addiction concept, leaving it perilously close to the sort of 
“virtus dormitiva” explanation sharply lampooned by Moliere. 
 
 
 
 
 
ARGUMENTS IN FAVOR OF FOOD ADDICTION (KENNY) 
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“My drug of choice is food. I use food for the same reasons an 
addict uses drugs: to comfort, to soothe, to ease stress.” 
 
-Oprah Winfrey 
 
The term ‘addiction’, even when used in the context of drug abuse, is highly contentious. It 
means different things to different people; those suffering from the disorder or their loved 
ones, health care professionals, researchers, self-help groups, religious organizations and 
government agencies all have their own views on what it means to be an addict. For this 
reason, discrete behavioral characteristics in affected individuals that are considered core 
features of the disorder have been codified into checklists that are used in the formal diagnosis 
of substance use disorders (SUDs) (American Psychiatric Association, 2013). It is little wonder 
then that the term addiction is so controversial when used in the context of food consumption. 
I hesitate to position myself as a defender of the concept of food addiction when it is such a 
nebulous term so open to misinterpretation. However, I consider it self-evident that at least 
some overweight individuals struggle to control their food intake even when their health and 
wellbeing depend on it in a manner that is analogous or even homologous to those affected by 
SUDs who struggle to control their drug use. After all, SUDs across different classes of drugs 
with different pharmacological actions are not defined by any shared physiological abnormality 
that can be objectively measured and used as a diagnostic, such as the elevated blood glucose 
in the case of diabetes, but rather by the manifestation of a behavioral abnormality that 
negatively impacts their life: specifically, the failure to control consummatory behavior despite 
repeated attempts to do so. Consequently, I am a wiling defender of the notion that a history of 
overconsumption of energy-dense palatable food can remodel brain motivation circuits in a 
manner that renders some overweight individuals persistently vulnerable to the desirable 
properties of such food, which negatively impacts their health and wellbeing. 
 
Food addiction, as currently diagnosed using the YFAS and related scales, is considered distinct 
from obesity. However, the negative consequences associated with a failure to control food 
intake are most obvious in overweight individuals, who often suffer social stigmatization and 
are at far greater risk of diabetes, cardiovascular disease, cancer and other significant health 
concerns than lean individuals. For this reason, I have framed the arguments below in the 
context of overweight and obesity, but this should not disguise the fact that many lean 
individuals also suffer from patterns of dysregulated eating that share many features with 
SUDs.  
 
Three of the most important clinical features of SUDs are feelings of deprivation when the 
substance is withheld, a propensity to relapse during periods of abstinence, and consumption 
that persists despite awareness of negative health, social, financial or other consequences. 
Overweight individuals who experience real or perceived social, emotional or health 
consequences because of their body weight will often express a desire to lose weight and will 
repeatedly attempt to do so (Booth et al, 2008; Puhl et al, 2008), but limiting their food intake 
or the types of food that they consume over the prolonged time periods necessary to achieve 
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and maintain a healthy body weight is notoriously difficult. Even those overweight individuals 
who turn to surgical interventions, highlighting their struggle to exert self-control over their 
diet, demonstrate remarkably high rates of recidivism, with many gradually increasing their 
consumption of energy-dense food items and regaining previously lost body weight over time 
(Saunders, 2001). Hence, overweight individuals who are unable to exert control over their 
consummatory behavior, despite awareness of the negative consequences, demonstrate the 
same core failure to control consumption as those suffering from SUDs. 
 
An issue often raised in context of food addiction is whether the same brain systems are 
involved in relapse to weight gain in previously overweight individuals, through their failure to 
control the amount, frequency or type of food consumed, as those systems involved in relapse 
to drug use in SUDs. The underlying assumption being that unless a core brain system involved 
in drug addiction is similarly impacted in those struggling to control their diet, then the 
construct of addiction should not be applied to food. There is now a preponderance of human 
functional imaging data showing that energy-dense palatable food can stimulate changes in the 
activity of many of the same brain circuits known to be impacted by drugs of abuse. For 
example, palatable food stimulates reward-relevant activity in the striatum (Small et al, 2001; 
Stice et al, 2011; Yokum et al, 2014). Moreover, weight gain is associated with altered striatal 
responses to palatable food or cues that predict the availability of such food (Stice et al, 2008; 
Stice and Yokum, 2016; Stice et al, 2010), and allelic variation that influences vulnerability to 
weight gain and obesity can profoundly alter reward-relevant activity in the striatum (Stice et 
al, 2008; van der Klaauw et al, 2014). In addition to the striatum, the activity of other brain 
areas thought to play an important role drug addiction, such as prefrontal cortical regions and 
the amygdala, is similarly altered by consumption of palatable food and development of obesity 
(Holsen et al, 2005; Killgore et al, 2013; Killgore et al, 2003; Scholtz et al, 2014; Siep et al, 2009; 
van Bloemendaal et al, 2014). The animal literature is also replete with evidence that palatable 
food and drugs of abuse can impact similar brain circuits, particularly the mesoaccumbens 
dopamine system, and that the development of obesity profoundly alters the function of these 
same circuits (Bassareo and Di Chiara, 1999; Blackburn et al, 1986; Geiger et al, 2009; Martel 
and Fantino, 1996; Wilson et al, 1995). Hence, palatable food and weight gain profoundly 
impact activity and responsiveness of core components of the brain reward system. But which 
type of brain abnormality in drug users should be considered the true hallmark of addiction to 
which changes in the brains of overweight individuals should be compared? It seems 
unreasonable to assume that there is a specific addiction-relevant pattern of brain activity, at 
least those patterns that can be detected using current imaging modalities, that can be used to 
support or refute the existence of food addiction when the very same imaging approaches 
cannot be used as a diagnostic for drug addiction. Currently, all that can be concluded from 
these imaging studies is that palatable food and drugs of abuse can impact the function of 
similar regions of the brain. Ultimately, the value of identifying overlapping brain systems 
involved in regulating the motivational properties of palatable food and drugs of abuse rests on 
whether such knowledge facilitates the development of therapeutics that reduce problematic 
overeating and drug use. Available evidence is promising in this regard. For example, the 
cannabinoid receptor 1 (CB1) antagonist Rimonabant, developed as an anti-obesity drug, 
facilitates smoking cessation in humans (Cahill and Ussher, 2007). Similarly, the anti-obesity 
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drug Lorcaserin, a serotonin 2C receptor antagonist, also facilitates smoking cessation 
(Shanahan et al, 2017). These findings suggest that common underlying brain processes are 
involved in overeating and drug use.  
 
Another argument often used against the notion of a food-directed use disorder is the question 
of which ingredient in food is the responsible agent. The underlying assumption here is that 
only those food items that contain this agent will support addiction-relevant behaviors. 
Recently, arguments have been made for the involvement of refined sugars (Ahmed et al, 2013; 
Colantuoni et al, 2002). My own view is that it is not necessarily a single macronutrient that is 
responsible for maladaptive eating but rather the combinations of macronutrients in palatable 
high-calorie food items that do not occur naturally, but that when combined can pack a supra-
physiological punch to brain motivation circuits that is sufficient to modify subsequent 
consummatory behaviors. Emerging evidence suggests that this may indeed be the case. For 
example, a recent study in humans found that blended food items high in both fat and 
carbohydrate were more valued than palatable food items high in fat or carbohydrate alone, 
and that the blended food had a greater impact on the activity on brain areas involved in 
reward than the single nutrient food items (DiFeliceantonio et al, 2018). Hence, diets consisting 
of palatable food items that are rich in energy-dense macronutrients may render less palatable 
but healthier food options less attractive and shift dietary preferences toward these highly 
rewarding, calorie-laden options.  
 
Addiction should not be viewed as a single unitary disorder, related to core deficits in one or 
more of the same brain system and distinguished only by the users’ drug of choice. Instead, use 
disorders should be viewed as a constellation of related syndromes that share similar but not 
entirely overlapping brain and behavior abnormalities, the most conspicuous of which is a 
failure to control consumption. Indeed, core features of SUDs can differ dramatically depending 
on which substance is being used, reflecting different underlying neurobiological processes at 
play. For example, cocaine use disorder is characterized by cycles of binge consumption 
interspersed by periods of abstinence, with the amounts of cocaine used sufficient to induce 
intoxication and often exceeding the amounts that the user wished to limit themselves to, 
resulting in overt signs of over-dosing (Decorte, 2001). By contrast, tobacco use disorder is 
characterized by remarkably stable and highly regular patterns of daily use, with no overt signs 
of intoxication, and binge-like consumption not a general feature of the habit (National Center 
for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 
2014). Yet, considering the well-known detrimental health consequences of tobacco smoking, 
and the struggle that habitual smokers experience when trying to quit, it is difficult to argue 
that a tobacco smoker is any less ‘addicted’ than someone who binges on cocaine. It is worth 
pointing out that until recently tobacco smoking was also the subject of much heated debate 
about whether it constituted a simple habit or warranted the moniker of full-blown addiction 
(Russell, 1974; Warburton, 1989). Before that, the same type of debate centered on cocaine 
(Gawin, 1991). When viewed from this perspective, it should come as no surprise that 
overweight individuals who struggle to control their food intake will show brain and behavior 
abnormalities that are similar in some respects to the prototypic features of psychomotor 
stimulant, alcohol, tobacco or opioid addiction, yet differ from these disorders in much the 
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same way that these drug addictions differ from each other. Ultimately, the questions we must 
ask when considering whether food consumption can, in some circumstances, be considered a 
use disorder are: Does the affected individual fail to exert control over consummation of a 
substance from which they derive pleasure despite knowledge of potentially severe 
consequences? Does the affected individual experience feelings of deprivation when the 
substance is not available or they try to abstain? Does the affected individual show vulnerability 
to relapse during periods of abstinence? For some overweight individuals at least, the answer 
to each of these questions is a resounding yes. Precisely how these features can be codified 
into checklists of symptoms to identify individuals who are most affected, and the utility of such 
checklists in a clinical or research setting, should not distract from struggle that some 
individuals face when trying to exert control over their diet. 
 
Ultimately, I agree with those who express concern about the concept of food addiction. This 
concept is too nebulous and loaded to convey proper meaning. However, some individuals 
clearly demonstrate a failure to exert control over their food choices, despite a desire to do so, 
and as a result experience significant negative consequences. Our ever-increasing 
understanding of how drugs of abuse remodel motivation circuits in the brain to precipitate 
compulsive drug use can and should serve as a heuristic to better understand the brain 
mechanisms of overeating in overweight individuals.  
 
HOW TO MOVE THE FIELD FORWARD 
We both agree that questions on the concept of food addiction are heavily confounded by 
terminology. As noted above, the term addiction is simply too imprecise to be meaningful from 
a clinical perspective. We also agree that there are patterns of behavior and subjective 
experiences related to food consumption that bear a resemblance to SUDs, most notably the 
strong urge to consume, which can become more powerful with abstinence and over-ride 
personal desires to limit consumption. Where we differ is on the issue of the biological 
equivalence between those struggling to control their food or drug intake and whether this 
signifies a deeper resemblance between overeating and drug addiction. More specifically, do 
strong urges to consume food simply reflect innate biological drives, which can differ between 
individuals, and which are undoubtedly further influenced by patterns of over-consumption and 
ensuing weight gain but which should not be conflated with the notion of an addict seeking 
drugs (Fletcher)? Or, instead, are such urges and associated overeating reflective of a 
breakdown of behavioral control systems related to neurobiological abnormalities that can be 
considered analogous or even homologous to those that contribute to SUDs (Kenny)? These 
differences in opinion speak directly to whether the diagnosis of ‘food addiction’, as defined by 
existing instruments such as the Yale Food Addiction Scale (YFAS) or other instruments that will 
likely emerge in coming years, captures a legitimate clinical entity that is distinct from other 
patterns of disordered eating. 
 
A critical evaluation of the concept of food addiction should not seek to undermine the 
personal and clinical reality of those experiencing strong urges to consume. Instead, the focus 
should be placed firmly on generating empirical evidence that supports or refutes this concept. 
Perhaps the most practical scientific strategy to explore the case for food addiction is to begin 
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with our current understanding of how drugs of abuse remodel brain motivation circuits to 
precipitate compulsive drug seeking, and factors that influence this process. Critically, this 
approach might adopt two core principles. First, it begins not by assuming that over-eating is a 
form of addiction, although it allows for the possibility that ultimately there may emerge 
evidence to suggest that at least certain forms of such over-consumption may show high levels 
of overlap. Rather, the initial aim would be a systematic approach, using insights from the drug 
addiction literature to focus and sharpen scientific questions relating to obesity.  Second, the 
emphasis would move away from focusing exclusively upon similarities between excessive food 
and substance use  and would acknowledge too the importance of differences in their patterns 
of use. The functional significance of both the commonalities and the differences in the over-
use of food and drugs should be explored together in order to generate a more complete 
picture of where the food addiction model succeeds and fails. Indeed, as with all useful models, 
one can learn as much from limitations as from its success. This is important because we both 
feel that current characterizations of the food addiction model lack the specificity that would 
make the model breakable: a sine qua non for a useful model (Teufel and Fletcher, 2016). 
Overall, we suggest, in demanding less dogmatic or polarized positions, this reframes the 
question to a much more scientifically compelling and tractable one.  
 
Practical difficulties present themselves when trying to apply drug addiction approaches to the 
question of food addiction. Even in the case of SUDs, where there is a known agent with an 
established pharmacology and the picture is not complicated by a preexisting innate biological 
need for the substance, the brain mechanisms are hugely complex, with pronounced variability 
across individuals and drugs. Despite this complexity, robust molecular, epigenetic, synaptic, 
cellular, and circuit-based adaptive responses to drugs of abuse, thought to be relevant to the 
emergence of compulsive drug use in humans, have been detected in laboratory animals (Russo 
et al, 2010). In addition, genetic vulnerabilities that influence these processes have been 
identified in recent years.  Of course, the complexities are magnified significantly in the context 
of food consumption, which is shaped and regulated by a host of parallel systems with built-in 
redundancies as well as by complex economic and sociocultural factors. We must consider, 
therefore, the appreciable challenges when applying concepts in drug addiction to understand 
food consumption. Nonetheless, some of the important (but by no means the only) concepts 
from the addiction literature that should be considered in the context of food consumption are: 
 
First, most major drugs of abuse profoundly dysregulate striatal glutamate homeostasis 
(Kalivas, 2004), such that environmental stimuli associated with their delivery can evoke 
‘supraphysiological’ increases in glutamate spillover particularly in the nucleus accumbens core 
(Scofield et al, 2016). Such cue-evoked increases in glutamate transmission trigger synaptic and 
structural plasticity in the striatum, reflected by alterations in AMPA/NMDA receptor ratios and 
new dendritic spine formation (Scofield et al, 2016). This action, in turn, is thought to 
contribute to vigorous drug seeking during periods of abstinence. Hence, it will be important to 
determine whether excessive consumption of palatable foods, and associated weight gain, also 
induces disruption in striatal glutamate homeostasis, a disruption that may perhaps offer 
important targets for therapeutic interventions aimed at curbing consumption or preventing 
relapse. The complexity of applying this aspect of the model to foods should not be 
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underestimated: for example, excessive consumption of palatable foods may not lead to weight 
gain (for example in bulimia nervosa). Moreover, in many cases, particularly of early onset 
obesity, primary disturbances lie outside striatum, for example within the leptin-melanocortin 
circuitry of the hypothalamus (O'Rahilly and Farooqi, 2008). Thus, a consideration of putative 
striatal alterations will need to be considered within a context of more extensive, albeit subtle, 
brain changes. 
 
Second, a history of extended access to psychomotor stimulants, alcohol or opioids in 
laboratory rodents and in human subjects is associated with profound deficits on brain reward 
function (Kenny et al, 2018). It has been hypothesized that drug-induced reward deficits 
precipitate the emergence of compulsive drug seeking behaviors (Koob and Le Moal, 2008), and 
are related to the recruitment of brain aversion and stress systems such as the κ opioid 
receptor-mediated transmission (Wee and Koob, 2010). Recently, it was shown that 
overconsumption of palatable energy-dense food and the development of obesity in laboratory 
rats similarly disrupts brain reward function (Johnson and Kenny, 2010). While consistent 
evidence has yet to emerge that this translates to human obesity, this finding suggests that 
homeostatic adaptive responses occur in brain reward circuits in response to overconsumption 
of rewarding food or drugs. It will be important to determine if common underlying 
neuromolecular mechanisms are involved in drug- and food-induced alterations in hedonic 
responsiveness. Moreover, will amelioration of these adaptive response in brain reward 
systems reduce the desire to use food and drugs in humans? 
 
Third, overconsumption of drugs of abuse can facilitate the emergence of habitual-like 
consummatory behaviors, characterized by their relative insensitivity to the current value of 
reinforcer that the animal is responding for (Ersche et al, 2016; Everitt and Robbins, 2005). The 
ability of drugs of abuse to enhance habitual-like patterns of responding may play a role in the 
persistence of the drug-taking habit. In addition, a history of extended drug access can 
precipitate drug-taking behaviors that become progressively less sensitive to negative 
consequences (Deroche-Gamonet et al, 2004; Vanderschuren and Everitt, 2004). Emerging 
evidence suggests that overconsumption of palatable food can similarly precipitate habitual- 
and compulsive-like patterns of food intake in rats (Johnson et al, 2010; Tantot et al, 2017) 
Hence, it will be important to determine if common underlying neurobiological mechanisms 
contribute to these addiction-relevant patterns of consumption and, again, if manipulating 
these processes may help to ameliorate over-consumption. It will, however, be profoundly 
challenging to determine whether rodent findings extend to humans given the challenges 
posed by precise but unobtrusive characterization of naturalistic eating behaviors and by 
difficulties in replicating the conditions under which habit-like responses can be generated, and 
thereby investigated, in humans (https://osf.io/5pbmz/). 
 
Forth, drug addiction is often hypothesized to reflect a state of ‘hypofrontality’ in which 
excessive drug use induces deficits in the function of higher-order cortical centers in the brain, 
resulting in a progressive loss of executive control over drug seeking behaviors (Chen et al, 
2013). Such conceptualizations often consider addiction as a circuit-based disorder, in which 
top-down signals from the cortex to limbic, basal ganglia and midbrain regions to inhibit 
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consummatory behavior progressively weaken whereas bottom-up urges to seek and consume 
drugs of abuse persist or even strengthen (Diana et al, 2017). Recent animals and human 
findings are consistent with a circuit-based view of drug addiction that is controlled by 
executive centers in the cortex (Chen et al, 2013; Terraneo et al, 2016). Hence, it will be 
important to thoroughly explore the consequences of overconsumption of palatable energy-
dense food on cortical control centers in laboratory animals and humans. Emerging data 
suggest that higher-order cortical systems indeed undergo robust remodeling in response to 
such diets (Thompson et al, 2017), but the functional consequences of such cortical remodeling 
remains poorly understood. Moreover, though ventromedial prefrontal cortex in humans is 
emerging as a consistent site of structural change in relation to elevated body weight (Medic et 
al, 2016), the functional significance of this is by no means clear and functional neuroimaging as 
a whole does not support any simple notions of hypofrontality as a causative or maintaining 
factor in obesity. 
 
Fifth, we both agree that using ‘overeating’ as a metric for addiction is problematic, as it is not 
necessarily the amount of food that is consumed but rather the type and pattern of 
consumption that is the issue. Drug addiction is often conceptualized as a disorder of decision-
making, whereby the value of the drug increases to the point that the user will choose to 
consume the drug at the expense of competing natural reinforcers or behaviors. In recent 
years, Ahmed and colleagues have shown that the majority of rodents, when presented with a 
mutually exclusive choice between a natural reward such as sucrose or a drug reward, such as a 
cocaine infusion or delivery of alcohol, will select the natural reward over the drug reward 
(Cantin et al, 2010; Freese et al, 2018; Huynh et al, 2017; Lenoir et al, 2013; Madsen and 
Ahmed, 2015). Only a small minority of animals will select the drug reward, with this population 
considered the ‘addiction vulnerable’ animals. Most recently, it was shown that constitutively 
enhanced GABAergic transmission in the central nucleus of the amygdala may explain the 
increased value of alcohol in vulnerable animals, as reflected by their choice to consume 
alcohol at the expense of competing saccharin rewards (Augier et al, 2018). Currently, very little 
is known about the neurobiological mechanisms that regulate the choice to consume palatable 
energy-dense food at the expense of healthier but less palatable options and the role that 
intermittency of access to palatable food can play in influencing such choices (Corwin, 2011). 
The use of choice procedures similar to those championed by Ahmed to understand 
maladaptive choice behaviors in the context of drug addiction may facilitate greater 
understanding of how long-lasting shifts in dietary preferences toward highly rewarding energy-
dense food items can occur.  
Sixth, large-scale genome-wide association studies (GWASs) in humans are beginning to identify 
genetic variants that are robustly associated with complex traits or phenotypes, such as 
cannabis use (https://www.biorxiv.org/content/early/2018/01/08/234294), problematic 
alcohol use (see https://www.biorxiv.org/content/biorxiv/early/2018/03/08/275917.full.pdf), 
levels of tobacco smoking (Thorgeirsson et al, 2008) and measures of adiposity (Locke et al, 
2015). If substance use and obesity do share a common aetiology, these studies are well-suited 
to identify and characterize it. While early candidate gene studies have suggested such overlap, 
these have proved to be inconsistent; e.g., (Munafo et al, 2007). Moreover, initial results from 
these GWAS suggest that the genetic variants that confer risk for substance use phenotypes do 
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not substantially increase risk for obesity—if at all. In fact, results from these GWAS suggest 
that the common variant genetic architecture of substance use and obesity are largely unique 
from one another despite having high expression levels in brain tissue (Locke et al, 2015; 
Sanchez-Roige et al, 2018). It should be borne in mind that this is a field that is developing 
rapidly and changing techniques and emerging findings will require careful monitoring with 
respect to the question at hand. 
It is important to bear in mind that, while we here support for the view of drug use as a 
potential, albeit simplified, model for aberrant food  intake,  many of the gains that have been 
made in our understanding of drug use has been based on the reverse modeling process – 
specifically, by considering it in terms of a hijacking of the systems underlying natural rewards, 
including foods. There is no contradiction here. While it would certainly be circular to argue, as 
some have done, that, because foods activate reward circuitry this suggests that foods are as 
perilous as drugs, it is nonetheless useful to take an iterative approach in which observations of 
perturbations associated with substance use can contribute to guiding and interpreting 
observations related to health-harming over-consumption, and vice versa. But such an 
approach must acknowledge notable differences between obesity and drug addiction. Reward 
circuitry, which is the core focus of both, does not function in isolation from other homeostatic 
and higher order functions of the brain or from the powerful effects of neural, hormonal and 
metabolic signals from the rest of the body. As well as modulating reward-related circuitry 
(Farooqi et al, 2007), these signals have the capacity to shift and shape higher order cognition 
and perception (Owens et al, 2018; Tallon-Baudry et al, 2018). With this in mind, it is important 
to consider whether mechanisms of appetitive regulation can provide a conceptual framework 
to better understand drug addiction. All vertebrates have whole organ systems adapted to 
sense, consume, digest, and eliminate food, and each level of this process involves exquisitely 
controlled bidirectional communication between these organ systems and those brain systems 
involved in appetite control. Consequently, those interested in obesity, binge eating and other 
forms of disordered eating do not view the brain in isolation but rather take a holistic view of 
the body and how it is perturbed in affected individuals. Indeed, slower hormonal and faster 
vagally transmitted signals from organ systems involved in energy homeostasis, such as the 
pancreas, liver and gut, are central to any conceptualization of disordered feeding behaviors 
and associated diseases. With the exception of alcohol use (Morris et al, 2018),  research 
conducted into the role of organ systems other than the brain in drug addiction has been 
sparse. Do peripheral organ systems transmit information to brain motivation circuits in 
response to drug consumption, and is such peripherally derived information relevant to 
addiction?  In addition to hunger-related signals derived from peripheral organs that act on 
brain circuits to promote food intake, there are complex systems that serve to inhibit appetite, 
and failure of such appetite-suppressing systems is often incorporated into conceptualizations 
of overeating and obesity. Do circuits that inhibit food consumption also play a role in 
controlling drug intake, and does their dysregulation contribute to the emergence of drug 
addiction? These are important questions that can help bridge the fields of maladaptive food 
and drug consumption.  
 
We believe that even those who feel skepticism over the validity and current evidence base of 
the food addiction model would recognize the potential value and synergy in drawing these 
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fields together. There are many ways in which they may prove mutually informative. But 
information will be lost if we begin with the assumption that drug addiction processes explain 
food over-consumption and schedule our empirical endeavors exclusively towards a survey of 
similarities, some of which are superficial and imprecise. Ultimately, drug addiction could 
provide a useful model for aspects of food over-consumption, just as consumption of foods and 
other natural rewards serves a useful purpose to better understand drug addiction. Of course, 
such synergy may not necessarily translate directly to the clinic (Wilson, 2010) but it may well 
help to guide future targeted therapeutic efforts and contribute to our understanding of 
whether superficial clinical similarities are underpinned by a deeper resemblance. 
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